Phase II study of the histone deacetylase inhibitor belinostat (PXD101) for the treatment of myelodysplastic syndrome (MDS)
Titel:
Phase II study of the histone deacetylase inhibitor belinostat (PXD101) for the treatment of myelodysplastic syndrome (MDS)
Auteur:
Cashen, Amanda Juckett, Mark Jumonville, Alcee Litzow, Mark Flynn, P. J. Eckardt, John LaPlant, Betsy Laumann, Kristina Erlichman, Charles DiPersio, John